These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11361854)

  • 1. FDA clears drug trials to combat systemic CMV.
    AIDS Patient Care STDS; 1997 Aug; 11(4):295-6. PubMed ID: 11361854
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First oligonucleotide in U.S. clinical trials for CMV retinitis.
    AIDS Patient Care STDS; 1997 Jun; 11(3):198-9. PubMed ID: 11361805
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytovene capsules approved.
    J Physicians Assoc AIDS Care; 1995 Jan; 2(1):15. PubMed ID: 11362195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hopeful CMV drug stalled.
    Proj Inf Perspect; 1997 Jul; (22):13. PubMed ID: 11364570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ganciclovir approved.
    AIDS Treat News; 1995 Jan; (No 214):1. PubMed ID: 11362183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ganciclovir approved for CMV.
    Common Factor; 1995 Apr; (no 10):21. PubMed ID: 11362347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric drug development in anesthesiology: an FDA perspective.
    Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
    Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense drug closer to approval.
    AIDS Patient Care STDS; 1998 Oct; 12(10):805-6. PubMed ID: 11362033
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in antisense efficacy and delivery.
    Agrawal S; Akhtar S
    Trends Biotechnol; 1995 Jun; 13(6):197-9. PubMed ID: 7598842
    [No Abstract]   [Full Text] [Related]  

  • 12. The new antibiotics.
    Breithaupt H
    Nat Biotechnol; 1999 Dec; 17(12):1165-9. PubMed ID: 10585711
    [No Abstract]   [Full Text] [Related]  

  • 13. Fomivirsen approved for CMV retinitis.
    Roehr B
    J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):14-6. PubMed ID: 11365956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral ganciclovir for the prevention of illnesses caused by CMV].
    Vianna G
    Sidahora; 1995; ():33-4. PubMed ID: 11362479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 16. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV trial enrolling.
    Vazquez E
    Posit Aware; 1997; 8(4):13. PubMed ID: 11364480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational new drugs submitted to the Food and Drug Administration that are placed on clinical hold: the experience of the Office of Cellular, Tissue and Gene Therapy.
    Wonnacott K; Lavoie D; Fiorentino R; McIntyre M; Huang Y; Hirschfeld S
    Cytotherapy; 2008; 10(3):312-6. PubMed ID: 18418776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drug in expanded access.
    Vazquez E
    Posit Aware; 1998; 9(1):16. PubMed ID: 11364994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drug applications sought.
    AIDS Alert; 1995 Sep; 10(9):119-20. PubMed ID: 11362777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.